| pubmed-article:19698059 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19698059 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:19698059 | lifeskim:mentions | umls-concept:C0020616 | lld:lifeskim |
| pubmed-article:19698059 | lifeskim:mentions | umls-concept:C0441471 | lld:lifeskim |
| pubmed-article:19698059 | lifeskim:mentions | umls-concept:C0205082 | lld:lifeskim |
| pubmed-article:19698059 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:19698059 | pubmed:dateCreated | 2009-8-24 | lld:pubmed |
| pubmed-article:19698059 | pubmed:abstractText | This article reevaluates the hypoglycemic episodes reported as severe in the Treat-to-Target Trial comparing insulin glargine and NPH insulin use in patients with inadequately controlled type 2 diabetes. | lld:pubmed |
| pubmed-article:19698059 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19698059 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19698059 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19698059 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19698059 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19698059 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19698059 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19698059 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19698059 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19698059 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19698059 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19698059 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:19698059 | pubmed:issn | 1557-8593 | lld:pubmed |
| pubmed-article:19698059 | pubmed:author | pubmed-author:StrangePoulP | lld:pubmed |
| pubmed-article:19698059 | pubmed:author | pubmed-author:RiddleMatthew... | lld:pubmed |
| pubmed-article:19698059 | pubmed:author | pubmed-author:DaileyGeorgeG | lld:pubmed |
| pubmed-article:19698059 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19698059 | pubmed:volume | 11 | lld:pubmed |
| pubmed-article:19698059 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19698059 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19698059 | pubmed:pagination | 477-9 | lld:pubmed |
| pubmed-article:19698059 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:19698059 | pubmed:meshHeading | pubmed-meshheading:19698059... | lld:pubmed |
| pubmed-article:19698059 | pubmed:meshHeading | pubmed-meshheading:19698059... | lld:pubmed |
| pubmed-article:19698059 | pubmed:meshHeading | pubmed-meshheading:19698059... | lld:pubmed |
| pubmed-article:19698059 | pubmed:meshHeading | pubmed-meshheading:19698059... | lld:pubmed |
| pubmed-article:19698059 | pubmed:meshHeading | pubmed-meshheading:19698059... | lld:pubmed |
| pubmed-article:19698059 | pubmed:meshHeading | pubmed-meshheading:19698059... | lld:pubmed |
| pubmed-article:19698059 | pubmed:meshHeading | pubmed-meshheading:19698059... | lld:pubmed |
| pubmed-article:19698059 | pubmed:meshHeading | pubmed-meshheading:19698059... | lld:pubmed |
| pubmed-article:19698059 | pubmed:meshHeading | pubmed-meshheading:19698059... | lld:pubmed |
| pubmed-article:19698059 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19698059 | pubmed:articleTitle | Reconsideration of severe hypoglycemic events in the treat-to-target trial. | lld:pubmed |
| pubmed-article:19698059 | pubmed:affiliation | Scripps Clinic, La Jolla, California 92037, USA. Dailey.George@scrippshealth.org | lld:pubmed |
| pubmed-article:19698059 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19698059 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
